Mustang Bio, Inc. (“Mustang”) is a clinical-stage bio-pharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Mustang has partnered with top medical institutions to advance the development of CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as a lentiviral gene therapy for XSCID.
|
|
|
51-200 employees
View all Mustang Bio employees
|
|
Biotechnology
|
|
377 Plantation St, Worcester, Massachusetts 01605, US
|
Manuel Litchman is the CEO of Mustang Bio. To contact Manuel Litchman email at [email protected] or [email protected]. Or you may call +1-973-462-7549 or 4019354869
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.